Johnson & Johnson
VerifiedResearch and development, manufacture and sale of a range of products in the healthcare field.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$357.5b (Public information from Jun 2024)
Share price
$148.75 JNJ
New Brunswick New Jersey (HQ)
Deals in current and previous year:
Corporate Venture Fund: Johnson & Johnson Innovation
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 1 % | 14 % | 1 % | (10 %) | 4 % | 3 % | 3 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 25 % | 27 % | 25 % | 38 % | 36 % | 36 % | 37 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 18 % | 22 % | 19 % | 41 % | 25 % | 25 % | 26 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 15 % | 16 % | 16 % | 18 % | - | - | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Johnson & Johnson
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
By Industry
ACQUISITION by Johnson & Johnson Nov 2008
ACQUISITION by Stryker Mar 2019
ACQUISITION by Johnson & Johnson Aug 2020
ACQUISITION by Johnson & Johnson Jul 2018
ACQUISITION by Johnson & Johnson Jan 2024
ACQUISITION by Johnson & Johnson Nov 2015